GRM1 and spinocerebellar ataxia type 1: Notartomaso et al. [29] showed that, in a SCA1 model mouse, the metabotropic glutamate receptor 1 (mGlu1) receptor is reduced in the cerebellum, and that ataxic symptoms could be reverted by administration of a mGlu1 receptor positive allosteric modulator.